The amazing rise and shocking fall of the company that created Ozempic

A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its crown?

Raccontata dacincodias.elpais.comtheguardian.comtelegraph.co.uknytimes.com